GlassScriptPhysician profile
Uma Maduekwe
NPI 1144531237
$12,723.98
in general payments reported to CMS, 2019-2025
15 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $901 · 2020: $19.22 · 2021: $1,505 · 2022: $7,072 · 2023: $2,610 · 2024: $468 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,872 · Travel and Lodging: $1,354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,872.25 |
| Travel and Lodging | $1,353.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,908.09 | 2022 | |
| Axogen | $3,374.40 | 2021-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Smith+Nephew, INC. | $1,652.78 | 2022 | |
| Medwest Associates | $1,234.60 | 2022 | |
| Checkpoint Surgical, INC | $565.48 | 2022-2023 | Checkpoint Stimulators |
| Kls-Martin L.P. | $491.08 | 2020-2025 | |
| Stryker Corporation | $441.72 | 2019-2024 | Variax |
| Zimmer Biomet Holdings, INC. | $261.61 | 2019-2021 | |
| Polynovo North America LLC | $154.47 | 2024 | Novosorb Btm |
| Integra Lifesciences Corporation | $146.02 | 2019 | |
| Biocomposites INC | $120.00 | 2021 | |
| Mentor Worldwide LLC | $116.25 | 2019 | |
| Endo Pharmaceuticals INC. | $106.67 | 2022 | |
| Wardlow Enterprises | $82.76 | 2022 | |
| Allergan, INC. | $68.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uma Maduekwe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.